Copperwynd Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
1,482
-288
-16% -$224K 0.29% 60
2025
Q1
$1.46M Sell
1,770
-2,460
-58% -$2.05M 0.4% 46
2024
Q4
$3.27M Buy
4,230
+211
+5% +$175K 0.9% 22
2024
Q3
$3.56M Buy
4,019
+40
+1% +$36K 1.07% 16
2024
Q2
$3.2M Buy
3,979
+243
+7% +$194K 1.05% 18
2024
Q1
$2.91M Buy
3,736
+405
+12% +$288K 1.05% 17
2023
Q4
$1.94M Buy
3,331
+877
+36% +$512K 0.77% 20
2023
Q3
$1.32M Sell
2,454
-1,885
-43% -$971K 0.62% 27
2023
Q2
$2.03M Buy
+4,339
New +$1.82M 0.95% 23
2022
Q2
Sell
-8,181
Closed -$2.34M 129
2022
Q1
$2.34M Buy
8,181
+7,121
+672% +$1.83M 0.97% 24
2021
Q4
$293K Buy
+1,060
New +$269K 0.11% 105
2019
Q3
Sell
-12,183
Closed -$1.35M 109
2019
Q2
$1.35M Buy
12,183
+503
+4% +$59.2K 0.78% 28
2019
Q1
$1.52M Buy
+11,680
New +$1.42M 0.91% 26

Other funds holding LLY

Copperwynd Financial's LLY Position: Q2 2025 in Review

Copperwynd Financial reduced its Eli Lilly (LLY) stake by 16% in Q2 2025, selling an estimated $224K and leaving 1,482 shares worth $1.16M. The position accounts for 0.29% of the portfolio, ranked #60.

Copperwynd Financial first reported a position in LLY in Q1 2019 and has held it in 13 quarters since. The position peaked at $3.56M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Copperwynd Financial held 1,482 shares of Eli Lilly worth $1.16M as of Q2 2025.
  • Copperwynd Financial sold 288 Eli Lilly shares in Q2 2025, an estimated $224K.
  • Eli Lilly made up 0.29% of Copperwynd Financial's portfolio in Q2 2025, its #60 holding.
  • Copperwynd Financial first reported a position in Eli Lilly in Q1 2019 and has held it in 13 quarters since.
  • Copperwynd Financial's Eli Lilly position peaked at $3.56M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Copperwynd Financial's 13F filing for Q2 2025, filed 24 Jul 2025.